U.S. Tobacco Stock News

Ever wondered if Academy Sports and Outdoors stock is trading at a bargain or carrying a hidden premium? You are not alone; investors everywhere are asking whether now is the right time to buy or watch from the sidelines. The stock has caught some attention lately, climbing 9.2% this past week, even as it is still down nearly 15% year-to-date and just about flat over the last year. One reason for the recent moves is sector-wide optimism following positive consumer spending data, which has...

Booking Holdings (BKNG) delivered third-quarter earnings that topped expectations, supported by its Connected Trip strategy, expanding loyalty programs, and AI features. The company also raised its revenue and profit guidance for the rest of the year. See our latest analysis for Booking Holdings. After a year marked by ambitious tech rollouts and upbeat financials, Booking Holdings’ share price sits at $4,914.69. While the 1-year total shareholder return is down 4.8%, longer-term investors...

Thinking about whether Raymond James Financial is worth your investment attention? Let’s dig into what the numbers and some recent events might mean for its true value. The stock has shown some short-term momentum with a 2.3% gain over the past week, though it remains roughly flat year-to-date and is still down 6.3% over the last year after strong gains in the past few years. Recent headlines have focused on Raymond James Financial’s expansion of its wealth management services and strategic...

Ambarella (AMBA) drew extra attention after its fiscal third-quarter results showed a strong year-over-year revenue jump and improved profitability. The company raised its full-year revenue outlook, indicating continued business momentum. See our latest analysis for Ambarella. Even with brisk revenue growth and a raised outlook, Ambarella’s share price has seen sharp swings lately, tumbling nearly 14% over the past 30 days and surrendering much of this quarter’s momentum. Still, longer-term...

Precigen (PGEN) recently received FDA approval for PAPZIMEOS in adults with recurrent respiratory papillomatosis and secured a new credit facility, which extends its cash runway into 2027 and supports its cash flow breakeven goals. See our latest analysis for Precigen. Precigen’s share price story this year has been equally dramatic, with a year-to-date gain of 254.6% following FDA approval news and the extended credit facility. Short-term price swings remain volatile. The company’s 1-year...

If you have ever wondered whether Topgolf Callaway Brands is a bargain, overpriced, or somewhere in between, you are not alone. This article is for you. The stock has been on a tear lately, jumping 27.6% in the past week, 35.7% over the past month, and an eye-catching 53.3% in the last year. This has put growth potential front and center. Much of this momentum can be attributed to a wave of optimism after the company announced new strategic partnerships and high-profile...

Wondering if Mattel is a smart buy right now? If you are curious whether the current stock price means good value, you are in the right place for a deep dive. Mattel’s shares have moved up 6.5% in the past week, gaining 11.0% over the last month and surging 19.1% year-to-date. This signals renewed investor interest and potential growth momentum. Recent headlines spotlight Mattel’s strategic partnerships and new toy releases, including collaborations with Marvel and Disney, which have caught...

McEwen (NYSE:MUX) is back in the spotlight after recent analyst commentary highlighted how the company took advantage of higher gold and silver prices to boost cash flow, even though production decreased last quarter. See our latest analysis for McEwen. McEwen’s momentum has been hard to miss lately, with its 1-day share price jump of 4.2% capping off a run that saw the stock surge 61% over the past 90 days. The company’s year-to-date share price return of 125% and a standout total...

Wondering if Southwest Airlines is a hidden bargain or if the stock price is flying a bit too high? Here is what you should know before making your next move. The stock has been on the move lately, up 6.1% in the past week and gaining 13.5% over the last month. These changes have caught the attention of investors looking for growth or shifts in market sentiment. These recent jumps follow news of changes in the airline industry landscape, including renewed travel demand and updates on...

Curious if PG&E’s share price offers real value right now? You are not alone, as many investors are looking under the hood to see what is driving this utility stock. PG&E shares moved up by 2.9% in the past week and 2.3% over the last month, but they are still down 19.4% year-to-date and 25% over the last twelve months. This hints at lingering uncertainty and changing risk perceptions. Recent headlines have centered around settlement progress related to wildfire liabilities, which has...

MSCI (MSCI) has caught the market’s attention following a fresh round of buy and overweight calls from Wall Street. The company has also seen recent insider share purchases and ongoing executive transitions within the firm. See our latest analysis for MSCI. MSCI has traded in a fairly tight range this year despite policy changes and a continued stream of strategic updates, with the share price hovering near $563.45 and a one-year total shareholder return of -6.4%. While momentum has paused,...

Itron (ITRI) is deepening its international presence by teaming up with Connected Lighting Solutions in Australia to drive smarter urban lighting and by finalizing a significant deployment deal with Northumbrian Water Limited in the UK. See our latest analysis for Itron. Itron’s latest partnerships extend a strong run of international wins, yet these milestones come as the stock is rebounding from a rough patch. After a sharp 28% drop in its 1-month share price return, recent momentum is...

Vertex Pharmaceuticals recently announced updated data from its RUBY-3 trial, showing that povetacicept led to substantial reductions in proteinuria and stabilization of kidney function in patients with IgA nephropathy and primary membranous nephropathy. This candidate is currently the only BAFF+APRIL inhibitor in pivotal kidney disease trials, and Vertex is preparing for a rolling Biologics License Application submission for potential accelerated US FDA approval later this year. We'll...

Several analysts have recently raised their outlook for Liberty Energy (LBRT), while maintaining stable ratings. This highlights shifting investor sentiment and growing interest in the company’s market position and business prospects. See our latest analysis for Liberty Energy. Liberty Energy has shaken things up lately, with the stock jumping 8.5% over the past week after a strong run in the last quarter, even as it remains down year-to-date. Despite a one-year total shareholder return that...

Earlier this week, Argan, Inc. reported eight consecutive quarters of positive results, maintaining a robust financial profile with high institutional investor confidence and a low debt-to-equity ratio. This string of positive financial outcomes has further distinguished Argan within the construction sector, underlining its competitive industry standing and solid operational foundations. To assess how Argan's sustained financial strength influences its investment outlook, we’ll explore the...

ImmunityBio, Inc. recently presented at the Jefferies London Healthcare Conference 2025, sharing updates on its latest performance and product developments at the ME Hotel in London. A noteworthy highlight was the company’s significant third-quarter product revenue growth, driven by strong commercial demand for Anktiva in combination with BCG for BCG-unresponsive NMIBC with CIS. We’ll explore how robust Anktiva product uptake and higher revenue impact ImmunityBio’s investment narrative and...

Central Garden & Pet (CENT) just released its FY 2025 Q4 results, reporting revenue of $678 million and a basic EPS of -$0.16. Over the last year, the company has seen revenue change from $3.2 billion to $3.1 billion, while basic EPS moved up from $1.64 to $2.58. Margins have ticked higher, setting the tone for how investors interpret the latest release. See our full analysis for Central Garden & Pet. Now, let's see how these results stack up against the narratives driving Central Garden &...

Progressive (PGR) shares have dropped sharply after the company posted disappointing third-quarter earnings, as important measures like combined ratio and net premiums earned missed expectations. The pullback deepened because several analysts issued downgrades in response to the report. See our latest analysis for Progressive. Progressive’s sharp pullback comes on the heels of both a subdued third quarter and a flurry of analyst downgrades, but it’s worth noting that the recent selling may...

Axalta Coating Systems (AXTA) has seen its stock price fluctuate recently, catching the attention of investors who are observing varied short-term trends. The company’s results and strategy continue to be points of discussion for those interested in the materials sector. See our latest analysis for Axalta Coating Systems. After a choppy year, Axalta Coating Systems’ recent share price has started showing signs of stability, closing at $30.13 and reflecting subtle growth in recent weeks. While...

On November 24, 2025, Prologis, Inc. announced that Damon Austin will assume the role of Chief Development Officer effective January 1, 2026, following a decade of service in various senior leadership positions within the company. This transition places an experienced insider at the helm of development, underscoring Prologis’ ongoing expansion and focus on customer-led growth initiatives. We’ll explore how Mr. Austin’s appointment may impact Prologis’ development approach and broader...

One Stop Systems (OSS) introduced a new lineup of PCI Express 6.0 CopprLink cable adapters and a 4UPro-Max PCIe expansion accelerator, unveiling the suite at SuperComputing Conference 2025 in St. Louis. See our latest analysis for One Stop Systems. OSS’s big reveal at SuperComputing Conference 2025 comes after an impressive share price rally, with a year-to-date price return of 69% and a remarkable 1-year total shareholder return topping 156%. With momentum building thanks to product...

Kingsoft Cloud Holdings reported its unaudited third quarter 2025 results, revealing revenue of CNY 2,478.03 million and a net loss of CNY 4.62 million, both improvements compared to the previous year. The results marked a significant milestone as adjusted net profit turned positive for the first time, driven by increased AI cloud demand and strong expense management. We'll explore how Kingsoft Cloud's move to positive adjusted net profit reshapes its investment narrative and future profit...

Becton Dickinson (BDX) unveiled its BD Surgiphor Surgical Wound Irrigation System across select European countries following CE approval for the product. This marks a notable addition to its infection control and surgical offerings. See our latest analysis for Becton Dickinson. The Surgiphor launch is not happening in isolation. BD has also been investing in growth drivers such as the recent acquisition of Edwards Lifesciences’ Critical Care group and a board refresh, signaling a focus on...

Intercontinental Exchange (ICE) shares are drawing attention after modest gains this week, as investors weigh the company’s consistent financial results and long-term sector trends. With these movements, many are considering the underlying factors at play. See our latest analysis for Intercontinental Exchange. Intercontinental Exchange’s share price has steadily recovered from its recent dip, currently sitting at $157.3 after a 4.4% gain over the past month. While momentum has slowed since...